Join Now

Author Archives: Natalie Themm

PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update

PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022.

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®

PolarityTE announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. 

Posted in BioUtah News | Tagged | Leave a comment

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

Posted in BioUtah News | Tagged | Leave a comment

BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment

RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB.

Posted in BioUtah News | Tagged | Leave a comment

New Executive Appointments Position ARUP Laboratories for Future Growth

New Executive Appointments Position ARUP Laboratories for Future Growth

Posted in BioUtah News | Tagged | Leave a comment

First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIATM biopolymer surgical aortic heart valve.

Posted in BioUtah News | Tagged | Leave a comment

BioMérieux Joint Infection Panel Gets FDA De Novo Authorization

BioMérieux said on Wednesday that its BioFire Joint Infection (JI) Panel has received de novo authorization from the US Food and Drug Administration. 

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers

SALT LAKE CITY, May 3, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) today announced the enrollment of the first subject in the Phase III pivotal study evaluating SkinTE in the investigational use of treatment of Wagner grade 2 diabetic foot ulcers (DFUs), entitled “Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE,” or “COVER […]

Posted in BioUtah News | Tagged | Leave a comment

CenExel Acquires iResearch

Premier CNS-Focused Research Facilities in Georgia Join the CenExel Centers of Excellence Clinical Research Site Network

Posted in BioUtah News | Tagged | Leave a comment

IDbyDNA Improves Analytical Performance and User Experience of Its Explify Platform and Respiratory and Urinary Pathogen ID/AMR Panels

IDbyDNA develops Precision Metagenomic solutions with faster, comprehensive pathogen identification, quantification, and profiling powered by AI-driven genomic analysis and next-generation sequencing.

Posted in BioUtah News | Tagged | Leave a comment

Biotech Perfect Day opens Location in BioHive Hub

The Gateway, a growing campus for life sciences companies, will expand and diversify the footprint of Perfect Day’s technology capabilities and teams

Posted in BioUtah News | Tagged , | Leave a comment

Thermo Fisher Scientific Expands in Utah with New Bioprocessing Manufacturing Site in Ogden

Company now employs more than 2,000 people state-wide across three locations

Posted in BioUtah News | Tagged | Leave a comment